Amit Kumar1, Ganesh Chauhan1, Shriram Sharma1, Surekha Dabla1, P N Sylaja1, Neera Chaudhary1, Salil Gupta1, Chandra Sekhar Agrawal1, Kuljeet Singh Anand1, Achal Kumar Srivastava1, Deepti Vibha1, Ram Sagar1, Ritesh Raj1, Ankita Maheshwari1, Subbiah Vivekanandhan1, Bhavna Kaul1, Samudrala Raghavan1, Sankar Prasad Gorthi1, Dheeraj Mohania1, Samander Kaushik1, Rohtas Kanwar Yadav1, Anjali Hazarika1, Pankaj Sharma1, Kameshwar Prasad2. 1. From the Department of Neurology (A.K., A.K.S., D.V., R.S., R.R., A.M., K.P.), Department of Neurobiochemisty (S.V.), Dr. R. P. Centre for Ophthalmic Sciences (D.M.), and Cardio-Neuro Centre (A.H.), All India Institute of Medical Sciences, New Delhi; Centre for Brain Research (G.C.), Indian Institute of Science, Bangalore; Department of Neurology (S.S.), North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences, Shillong, Meghalaya; Department of Neurology (S.D.), Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana; Department of Neurology (P.N.S.), Sree Chitra Tirunal Institute for Medical Sciences and Technology, Kerala; Department of Neurology (N.C., B.K., S.R.), Vardhman Mahavir Medical College and Safdarjung Hospital; Department of Neurology (S.G., S.P.G.), Army Research and Referral Hospital; Department of Neurology (C.S.A.), Sir Ganga Ram Hospital; Ram Manohar Lohia Hospital (K.S.A.); Department of Biotechnology (S.K.), Maharshi Dayanand University, Government of India, New Delhi; Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (R.K.Y.), Rohtak, Haryana, India; and Institute of Cardiovascular Research Royal Holloway (P.S.), University of London, Imperial College London, UK. Amit Kumar, Kameshwar Prasad, and Ganesh Chauhan are currently at Rajendra Institute of Medical Sciences, Ranchi, India. 2. From the Department of Neurology (A.K., A.K.S., D.V., R.S., R.R., A.M., K.P.), Department of Neurobiochemisty (S.V.), Dr. R. P. Centre for Ophthalmic Sciences (D.M.), and Cardio-Neuro Centre (A.H.), All India Institute of Medical Sciences, New Delhi; Centre for Brain Research (G.C.), Indian Institute of Science, Bangalore; Department of Neurology (S.S.), North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences, Shillong, Meghalaya; Department of Neurology (S.D.), Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana; Department of Neurology (P.N.S.), Sree Chitra Tirunal Institute for Medical Sciences and Technology, Kerala; Department of Neurology (N.C., B.K., S.R.), Vardhman Mahavir Medical College and Safdarjung Hospital; Department of Neurology (S.G., S.P.G.), Army Research and Referral Hospital; Department of Neurology (C.S.A.), Sir Ganga Ram Hospital; Ram Manohar Lohia Hospital (K.S.A.); Department of Biotechnology (S.K.), Maharshi Dayanand University, Government of India, New Delhi; Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (R.K.Y.), Rohtak, Haryana, India; and Institute of Cardiovascular Research Royal Holloway (P.S.), University of London, Imperial College London, UK. Amit Kumar, Kameshwar Prasad, and Ganesh Chauhan are currently at Rajendra Institute of Medical Sciences, Ranchi, India. drkameshwarprasad@gmail.com.
Abstract
OBJECTIVE: To undertake a genome-wide association study (GWAS) to identify genetic variants for stroke in an Indian population. METHODS: In a hospital-based case-control study, 8 teaching hospitals in India recruited 4,088 participants, including 1,609 stroke cases. Imputed genetic variants were tested for association with stroke subtypes using both single-marker and gene-based tests. Association with vascular risk factors was performed with logistic regression. Various databases were searched for replication, functional annotation, and association with related traits. Status of candidate genes previously reported in the Indian population was also checked. RESULTS: Associations of vascular risk factors with stroke were similar to previous reports and show modifiable risk factors such as hypertension, smoking, and alcohol consumption as having the highest effect. Single-marker-based association revealed 2 loci for cardioembolic stroke (1p21 and 16q24), 2 for small vessel disease stroke (3p26 and 16p13), and 4 for hemorrhagic stroke (3q24, 5q33, 6q13, and 19q13) at p < 5 × 10-8. The index single nucleotide polymorphism of 1p21 is an expression quantitative trait locus (p lowest = 1.74 × 10-58) for RWDD3 involved in SUMOylation and is associated with platelet distribution width (1.15 × 10-9) and 18-carbon fatty acid metabolism (p = 7.36 × 10-12). In gene-based analysis, we identified 3 genes (SLC17A2, FAM73A, and OR52L1) at p < 2.7 × 10-6. Eleven of 32 candidate gene loci studied in an Indian population replicated (p < 0.05), and 21 of 32 loci identified through previous GWAS replicated according to directionality of effect. CONCLUSIONS: This GWAS of stroke in an Indian population identified novel loci and replicated previously known loci. Genetic variants in the SUMOylation pathway, which has been implicated in brain ischemia, were identified for association with stroke.
OBJECTIVE: To undertake a genome-wide association study (GWAS) to identify genetic variants for stroke in an Indian population. METHODS: In a hospital-based case-control study, 8 teaching hospitals in India recruited 4,088 participants, including 1,609 stroke cases. Imputed genetic variants were tested for association with stroke subtypes using both single-marker and gene-based tests. Association with vascular risk factors was performed with logistic regression. Various databases were searched for replication, functional annotation, and association with related traits. Status of candidate genes previously reported in the Indian population was also checked. RESULTS: Associations of vascular risk factors with stroke were similar to previous reports and show modifiable risk factors such as hypertension, smoking, and alcohol consumption as having the highest effect. Single-marker-based association revealed 2 loci for cardioembolic stroke (1p21 and 16q24), 2 for small vessel disease stroke (3p26 and 16p13), and 4 for hemorrhagic stroke (3q24, 5q33, 6q13, and 19q13) at p < 5 × 10-8. The index single nucleotide polymorphism of 1p21 is an expression quantitative trait locus (p lowest = 1.74 × 10-58) for RWDD3 involved in SUMOylation and is associated with platelet distribution width (1.15 × 10-9) and 18-carbon fatty acid metabolism (p = 7.36 × 10-12). In gene-based analysis, we identified 3 genes (SLC17A2, FAM73A, and OR52L1) at p < 2.7 × 10-6. Eleven of 32 candidate gene loci studied in an Indian population replicated (p < 0.05), and 21 of 32 loci identified through previous GWAS replicated according to directionality of effect. CONCLUSIONS: This GWAS of stroke in an Indian population identified novel loci and replicated previously known loci. Genetic variants in the SUMOylation pathway, which has been implicated in brain ischemia, were identified for association with stroke.
Authors: M Moussouttas; L Aguilar; K Fuentes; B Anyanwu; H Manassarians; N Papamitsakis; Q Shi; P Visintainer Journal: Neurology Date: 2006-09-12 Impact factor: 9.910
Authors: Katherine M Crawford; Cristina Gallego-Fabrega; Christina Kourkoulis; Laura Miyares; Sandro Marini; Jason Flannick; Noel P Burtt; Marcin von Grotthuss; Benjamin Alexander; Maria C Costanzo; Neil H Vaishnav; Rainer Malik; Jennifer L Hall; Michael Chong; Jonathan Rosand; Guido J Falcone Journal: Stroke Date: 2018-01-15 Impact factor: 7.914
Authors: Mihir A Kamat; James A Blackshaw; Robin Young; Praveen Surendran; Stephen Burgess; John Danesh; Adam S Butterworth; James R Staley Journal: Bioinformatics Date: 2019-11-01 Impact factor: 6.937
Authors: Steve Bevan; Matthew Traylor; Poneh Adib-Samii; Rainer Malik; Nicola L M Paul; Caroline Jackson; Martin Farrall; Peter M Rothwell; Cathie Sudlow; Martin Dichgans; Hugh S Markus Journal: Stroke Date: 2012-10-04 Impact factor: 7.914